Hanawa H, Izumi T, Saito Y, Ochiai Y, Okura Y, Inomata T, Hirono S, Ogawa Y, Saito R, Kodama M, Higuma N, Aizawa Y
First Department of Internal Medicine, Niigata University School of Medicine, Asahimachi, Japan.
Jpn Circ J. 1998 Mar;62(3):211-4. doi: 10.1253/jcj.62.211.
Giant cell myocarditis (GCM) is a rapidly progressive disease that leads to ventricular tachycardia or high-grade atrioventricular (A-V) block, frequently requiring a pacemaker. A 64-year-old woman developed syncope as a result of idiopathic GCM with A-V block. She required both a temporary and a permanent pacemaker. Two-dimensional echocardiography showed severely reduced wall motion. There was no histologic or clinical evidence to suggest sarcoidosis. Despite treatment with diuretics and an angiotensin-converting enzyme inhibitor, exertional dyspnea persisted. She received prednisolone 4 months after the onset of complete A-V block in the late phase of GCM. Prednisolone improved A-V nodal conduction in spite of the fact that there was no influence from LV wall motion, and sinus rhythm has continued for more than 2 years. In this patient, prednisolone was effective in the treatment of GCM.
巨细胞性心肌炎(GCM)是一种快速进展的疾病,可导致室性心动过速或高度房室传导阻滞,常常需要安装起搏器。一名64岁女性因特发性GCM伴房室传导阻滞而出现晕厥。她既需要临时起搏器也需要永久起搏器。二维超声心动图显示室壁运动严重减弱。没有组织学或临床证据提示结节病。尽管使用了利尿剂和血管紧张素转换酶抑制剂治疗,劳力性呼吸困难仍持续存在。在GCM晚期完全性房室传导阻滞发生4个月后,她开始接受泼尼松龙治疗。尽管左心室壁运动没有受到影响,但泼尼松龙改善了房室结传导,窦性心律已持续超过2年。在该患者中,泼尼松龙对GCM治疗有效。